reports
- Emma Ulker
Driven by safety and precision
Kanabo Group has listed on LSE Main Market raising £6m in an oversubscribed fundraising via an RTO and is poised to step up execution of the growth strategy for its high quality metered-dose vaporiser, VapePod®, which is specifically developed to give precision dosing of proprietary cannabinoid extract formulations for health and wellness markets. The rationale is driven by developing and commercialising premium products defined by safety, quality and user experience set against a highly dynamic...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.